Treating Neuropsychiatric Symptoms in Parkinson's Disease
This paper serves as a comprehensive review of approaches for treating neuropsychiatric symptoms in Parkinson's disease (PD). It highlights that these non-motor symptoms are highly prevalent, signific...
1 Kesä 202520min
Rituximab Use in Anti-NMDAR Antibody-Mediated Encephalitis Relapse Prevention
This multicenter cohort study investigated the effectiveness of rituximab in preventing relapses in adult patients diagnosed with anti-NMDAR antibody-mediated encephalitis. Researchers evaluated the i...
1 Kesä 202510min
Understanding Commercial Tissue-Based Assays for Autoimmune Neurologic Disorders
This episode combines two articles and discusses the importance of laboratory expertise in accurately diagnosing autoimmune neurological syndromes, particularly autoimmune encephalitis and paraneoplas...
25 Touko 202513min
Repeat Expansion Disorders in Neurology
This paper provides a comprehensive review of repeat expansion disorders, focusing on their significance in neurology. It explains how abnormal expansions of DNA repeats cause a wide range of neurolog...
23 Touko 202516min
Neurological IgG4-Related Disease: Diagnosis and Management
This paper is a comprehensive review of IgG4-related disease (IgG4-RD) as it affects the nervous system. It discusses the clinical presentation, diagnosis, and treatment of this rare inflammatory and ...
23 Touko 202518min
Long-Term Ravulizumab Efficacy and Safety in Generalized Myasthenia Gravis
This paper presents the final findings from the extended phase of a clinical trial called CHAMPION MG, investigating the long-term effectiveness and safety of ravulizumab for adults with a specific ty...
23 Touko 202514min
The Second European Carotid Surgery Trial (ECST-2)
This text summarizes interim results from the Second European Carotid Surgery Trial (ECST-2), a multicenter randomized trial comparing optimized medical therapy (OMT) alone versus OMT plus revasculari...
11 Touko 20259min
Inebilizumab Trial in Myasthenia Gravis
Published in New England Journal of Medicine the study details the MINT trial, a phase 3 clinical trial evaluating the efficacy and safety of inebilizumab for treating generalized myasthenia gravis (M...
6 Touko 202510min
